CYP19A1 and breast carcinoma: The decision to request a DXA scan in certain special situations (e.g., chronic liver disease, post- and pre-transplant solid or hematological malignancy, breast cancer, patients on aromatase inhibitors, patients on androgen ablation therapy, etc.)depends on the treating physician and can be considered in these special cases.